Loading...

CVS CVS HEALTH CORP Investments/Divestments 8-K Filing

CVS

CVS

CVS HEALTH CORP

(CVS)

2023 8-K

Earnings Report

Investor Day Update

Board Appointment

Earnings Report

Omnicare Bankruptcy

Debt Issuance Details

Financial Statements

Financial Statements

Management Changes

Earnings Announcement

Tender Offer Update

Tender Offer Results

Tender Offer Pricing

Management Changes

Earnings Announcement

CEO Appointment

Financial Results Announcement

Annual Meeting Approval

Financial Results Announcement

Financial Information

Financial Guidance Reaffirm...

Regulation FD Disclosure

Financial Information

Departure of CFO and Appoin...

Star Ratings Improvement

Appointment of Director

Reaffirmation of Guidance

Launch of Cordavis subsidiary

Pharmacy Service Providers ...

Financial Results Announcement

Segment Realignment and Fin...

Annual Meeting of Stockholders

Financial Information

Loan Agreement for Acquisition

Acquisitions and mergers

Merger Agreement

Financial Information

Merger Agreement

Management Changes

Earnings Guidance Update

External Links:

CVS Health has launched Cordavis, a subsidiary that will work with manufacturers to commercialize and/or co-produce biosimilar products in the US pharmaceutical market.

AI Assistant

CVS HEALTH CORP

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.